1. Pink Sheet
  3. >>User Fees

PDUFA VII Negotiations Completed, Commitment Letter Ratification Ongoing

 
• By Derrick Gingery

The US FDA, HHS and White House, as well as industry groups, now must sign off on the document.

Contract being signed with money present
The PDUFA commitment letter under consideration includes more funding to increase staffing at CBER. • Source: Shutterstock

The new prescription drug user fee commitments, which will serve as the base for program reauthorization in 2022, have started their long journey toward administration and industry approval.

Negotiations have officially concluded and the US Food and Drug Administration, as well as the industry trade associations, are reviewing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from User Fees

More from Pathways & Standards